688535 华海诚科
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.3954.50011.41220.89327.533
总资产报酬率 ROA (%)2.8143.6458.22811.4739.262
投入资产回报率 ROIC (%)3.2184.33811.39217.82115.801

边际利润分析
销售毛利率 (%)27.46626.88027.00729.14230.814
营业利润率 (%)15.87011.04113.71514.83412.601
息税前利润/营业总收入 (%)16.39411.98314.26016.58014.806
净利润/营业总收入 (%)14.55211.18413.59613.74611.135

收益指标分析
经营活动净收益/利润总额(%)43.87046.38884.97391.30297.361
价值变动净收益/利润总额(%)40.00841.1813.729-0.3750.114
营业外收支净额/利润总额(%)0.8177.5521.1844.1653.120

偿债能力分析
流动比率 (X)1.6731.8592.9812.6701.144
速动比率 (X)1.2231.3962.4092.1830.973
资产负债率 (%)17.67216.51425.08930.77265.710
带息债务/全部投入资本 (%)2.7601.983-2.802-2.83733.800
股东权益/带息债务 (%)3,422.3974,797.307-3,568.677-3,511.414175.071
股东权益/负债合计 (%)465.721505.565298.585224.97351.130
利息保障倍数 (X)41.685299.69637.42915.0518.232

营运能力分析
应收账款周转天数 (天)137.677151.918136.758104.492124.826
存货周转天数 (天)128.503127.137110.09976.10170.995